Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2004 1
2010 2
2013 2
2014 2
2015 2
2018 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial.
Misawa S, Kuwabara S, Sato Y, Yamaguchi N, Nagashima K, Katayama K, Sekiguchi Y, Iwai Y, Amino H, Suichi T, Yokota T, Nishida Y, Kanouchi T, Kohara N, Kawamoto M, Ishii J, Kuwahara M, Suzuki H, Hirata K, Kokubun N, Masuda R, Kaneko J, Yabe I, Sasaki H, Kaida KI, Takazaki H, Suzuki N, Suzuki S, Nodera H, Matsui N, Tsuji S, Koike H, Yamasaki R, Kusunoki S; Japanese Eculizumab Trial for GBS (JET-GBS) Study Group. Misawa S, et al. Lancet Neurol. 2018 Jun;17(6):519-529. doi: 10.1016/S1474-4422(18)30114-5. Epub 2018 Apr 21. Lancet Neurol. 2018. PMID: 29685815 Clinical Trial.
Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
Ruts L, Drenthen J, Jacobs BC, van Doorn PA; Dutch GBS Study Group. Ruts L, et al. Neurology. 2010 May 25;74(21):1680-6. doi: 10.1212/WNL.0b013e3181e07d14. Epub 2010 Apr 28. Neurology. 2010. PMID: 20427754
Second IVIg course in Guillain-Barré syndrome patients with poor prognosis (SID-GBS trial): Protocol for a double-blind randomized, placebo-controlled clinical trial.
Walgaard C, Jacobs BC, Lingsma HF, Steyerberg EW, Cornblath DR, van Doorn PA; Dutch GBS Study Group. Walgaard C, et al. J Peripher Nerv Syst. 2018 Dec;23(4):210-215. doi: 10.1111/jns.12286. Epub 2018 Sep 24. J Peripher Nerv Syst. 2018. PMID: 30151941
Group B streptococcal disease and genotypes in Australian infants.
Ko DW, Zurynski Y, Gilbert GL; GBS Study Group. Ko DW, et al. J Paediatr Child Health. 2015 Aug;51(8):808-14. doi: 10.1111/jpc.12830. Epub 2015 Feb 4. J Paediatr Child Health. 2015. PMID: 25656648
Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Samukawa M, Hamada Y, Kuwahara M, Takada K, Hirano M, Mitsui Y, Sonoo M, Kusunoki S; Japanese GBS Study Group. Samukawa M, et al. J Neurol Sci. 2014 Feb 15;337(1-2):55-60. doi: 10.1016/j.jns.2013.11.016. Epub 2013 Nov 19. J Neurol Sci. 2014. PMID: 24289889
Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany.
Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; GBS Study Group. Prestel J, et al. Pharmacoepidemiol Drug Saf. 2014 Nov;23(11):1192-204. doi: 10.1002/pds.3638. Epub 2014 May 10. Pharmacoepidemiol Drug Saf. 2014. PMID: 24817531 Free PMC article.
Pain in Guillain-Barre syndrome: a long-term follow-up study.
Ruts L, Drenthen J, Jongen JL, Hop WC, Visser GH, Jacobs BC, van Doorn PA; Dutch GBS Study Group. Ruts L, et al. Neurology. 2010 Oct 19;75(16):1439-47. doi: 10.1212/WNL.0b013e3181f88345. Epub 2010 Sep 22. Neurology. 2010. PMID: 20861454
Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation.
Davies HD, Raj S, Adair C, Robinson J, McGeer A; Alberta GBS Study Group. Davies HD, et al. Pediatr Infect Dis J. 2001 Sep;20(9):879-84. doi: 10.1097/00006454-200109000-00011. Pediatr Infect Dis J. 2001. PMID: 11734768
A multicentre prospective study of Guillain-Barré syndrome in Japan: a focus on the incidence of subtypes.
Mitsui Y, Kusunoki S, Arimura K, Kaji R, Kanda T, Kuwabara S, Sonoo M, Takada K; Japanese GBS Study Group. Mitsui Y, et al. J Neurol Neurosurg Psychiatry. 2015 Jan;86(1):110-4. doi: 10.1136/jnnp-2013-306509. Epub 2013 Nov 22. J Neurol Neurosurg Psychiatry. 2015. PMID: 24273220
Effect of methylprednisolone when added to standard treatment with intravenous immunoglobulin for Guillain-Barré syndrome: randomised trial.
van Koningsveld R, Schmitz PI, Meché FG, Visser LH, Meulstee J, van Doorn PA; Dutch GBS study group. van Koningsveld R, et al. Lancet. 2004 Jan 17;363(9404):192-6. doi: 10.1016/s0140-6736(03)15324-x. Lancet. 2004. PMID: 14738791 Clinical Trial.
Feedback